Lexaria Bioscience Corp. (LEXXW)
USD 0.64
(-20.58%)
USD 0.64
(-20.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 226.2 Thousand | 255.39 Thousand | 722.73 Thousand | 384.54 Thousand | 222.61 Thousand | 433.28 Thousand |
| Cost of Revenue | 31.5 Thousand | 71.84 Thousand | 175.34 Thousand | 99.37 Thousand | 22.89 Thousand | 25.18 Thousand |
| Gross Profit | 194.7 Thousand | 183.55 Thousand | 547.39 Thousand | 285.16 Thousand | 199.71 Thousand | 408.1 Thousand |
| Operating Expenses | 6.72 Million | 7.56 Million | 6.23 Million | 4.27 Million | 4.25 Million | 7 Million |
| Selling, General and Administrative Expenses | 3.06 Million | 5.72 Million | 4.97 Million | 3.77 Million | 3.64 Million | 6.51 Million |
| Research and Development Expenses | 3.66 Million | 1.84 Million | 1.26 Million | 387.07 Thousand | 555.73 Thousand | 492.86 Thousand |
| Other Expenses | - | - | - | 112.75 Thousand | 60.55 Thousand | 2307.00 |
| Cost and Expenses | 6.76 Million | 7.63 Million | 6.4 Million | 4.37 Million | 4.28 Million | 7.03 Million |
| Operating Income | -6.53 Million | -7.38 Million | -5.68 Million | -3.89 Million | -3.96 Million | -6.6 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -114.32 Thousand | -1.65 Million | -54.28 Thousand | 39.62 Thousand | -8968.00 |
| Earnings before Tax | -6.71 Million | -7.38 Million | -4.16 Million | -4.08 Million | -4.15 Million | -6.6 Million |
| Net Income | -6.66 Million | -7.26 Million | -2.5 Million | -4.03 Million | -4.19 Million | -6.59 Million |
| Earnings Per Share Basic | -1.01 | -1.24 | -0.57 | -1.45 | -1.62 | -2.79 |
| Earnings Per Share Diluted | -1.01 | -1.24 | -0.57 | -1.45 | -1.62 | -2.79 |
| Weighted Average Shares Outstanding | 6.61 Million | 5.88 Million | 4.39 Million | 2.77 Million | 2.59 Million | 2.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.61 Million | 5.88 Million | 4.39 Million | 2.77 Million | 2.59 Million | 2.36 Million |
| Gross Margin | 0.86 | 0.72 | 0.76 | 0.74 | 0.90 | 0.94 |
| EBIT Margin | -28.24 | -28.36 | -9.77 | -9.83 | -17.52 | -15.23 |
| Profit Margin | -29.46 | -28.46 | -3.47 | -10.48 | -18.86 | -15.23 |
| EBITDA | -6.38 Million | -6.51 Million | -5.57 Million | -4 Million | -4.09 Million | -6.6 Million |
| Earnings Before Tax Margin | -28.89 | -28.91 | -7.87 | -10.12 | -17.79 | -15.23 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 84 Thousand | 145 Thousand | 151.27 Thousand | 226.2 Thousand | -3433.00 | 93.15 Thousand |
| Cost of Revenue | 15.07 Thousand | 15.93 Thousand | 4822.00 | 31.5 Thousand | 3433.00 | 12.74 Thousand |
| Gross Profit | 68.92 Thousand | 129.06 Thousand | 146.45 Thousand | 194.7 Thousand | -6866.00 | 80.4 Thousand |
| Operating Expenses | 1.77 Million | 797.07 Thousand | 1.28 Million | 6.72 Million | 1.06 Million | 2.46 Million |
| Selling, General and Administrative Expenses | 1.2 Million | 551.29 Thousand | 711.1 Thousand | - | 566.67 Thousand | 823.32 Thousand |
| Research and Development Expenses | 573.08 Thousand | 245.77 Thousand | 574.49 Thousand | - | 500.4 Thousand | 1.64 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.79 Million | 813 Thousand | 1.29 Million | 6.76 Million | 1.06 Million | 2.47 Million |
| Operating Income | -1.7 Million | -668 Thousand | -1.13 Million | -6.53 Million | -1.07 Million | -2.38 Million |
| Interest Expense | - | 1.00 | - | - | - | - |
| Income Tax Expense | -2623.00 | -3195.00 | 40.18 Thousand | 130.87 Thousand | -9696.00 | -12.06 Thousand |
| Earnings before Tax | -1.78 Million | -652.73 Thousand | -1.18 Million | -6.71 Million | -1.24 Million | -2.38 Million |
| Net Income | -1.78 Million | -649.53 Thousand | -1.17 Million | -6.66 Million | -1.23 Million | -2.37 Million |
| Earnings Per Share Basic | -0.13 | -0.06 | -0.13 | - | -0.19 | -0.37 |
| Earnings Per Share Diluted | -0.13 | -0.06 | -0.13 | - | -0.19 | -0.37 |
| Weighted Average Shares Outstanding | 13.85 Million | 10.76 Million | 9.05 Million | 6.61 Million | 6.61 Million | 6.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.85 Million | 10.76 Million | 9.05 Million | 6.61 Million | 6.61 Million | 6.44 Million |
| Gross Margin | 0.82 | 0.89 | 0.97 | 0.86 | 2.00 | 0.86 |
| EBIT Margin | -20.16 | -4.50 | -6.99 | - | 291.17 | -25.32 |
| Profit Margin | -21.21 | -4.48 | -7.80 | -29.46 | 361.00 | -25.46 |
| EBITDA | -1.69 Million | -652.07 Thousand | -1.05 Million | - | -999.58 Thousand | -2.35 Million |
| Earnings Before Tax Margin | -20.34 | -4.61 | -7.53 | -28.89 | 311.83 | -25.59 |
UNIROYAL
CAT
0JVI
KESKBH
LGT
WENDT